Financial Performance - The company's operating revenue for the first half of 2020 was RMB 292.33 million, a decrease of 51.79% compared to RMB 606.42 million in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2020 was RMB 2.32 million, down 91.73% from RMB 28.07 million year-on-year[19]. - The net cash flow from operating activities was negative RMB 16.72 million, compared to positive RMB 62.51 million in the previous year[19]. - The total assets decreased by 8.98% to RMB 2.45 billion from RMB 2.69 billion at the end of the previous year[19]. - The basic earnings per share for the first half of 2020 was RMB 0.0042, a decrease of 91.76% from RMB 0.051 in the same period last year[20]. - The company reported a significant decline in net profit due to the impact of the pandemic on sales across all segments[22]. - The company’s revenue, excluding the impact of divested subsidiaries, decreased by 28.70% year-on-year[20]. - The weighted average return on net assets decreased by 1.44 percentage points to 0.11% compared to the same period last year[20]. - The company faced substantial losses in net profit attributable to shareholders after excluding non-recurring gains and losses, primarily due to the significant impact of the pandemic on its subsidiaries[22]. - The company reported a total of 10,405,228.26 in non-recurring gains and losses, after accounting for minority interests and tax impacts[24]. Business Segments and Operations - The company's main business segments are daily chemicals and pharmaceuticals, with a focus on oral care products and personal hygiene items[26]. - The Jiangsu subsidiary, primarily dealing with hotel supplies, experienced a significant revenue decline of approximately 36.60% and a net profit drop of 88.40% due to the pandemic[35]. - The company launched new products such as Artemisia annua hand sanitizers and handwashing liquids to explore new profit growth points[34]. - The company aims to expand its brand influence through new advertising strategies and collaborations with other brands[31]. - The company maintains a unified management model with specialized operations across its subsidiaries to maximize benefits[27]. - The daily chemical industry is expected to continue growing steadily, driven by economic growth and rising consumer spending, despite intense competition[30]. - The company has established a technology center and a research institute to focus on the development of new technologies and products in traditional Chinese medicine[31]. - The company is positioned as a leading toothpaste manufacturer in China, having achieved ISO9001 certification and being recognized as a national high-tech enterprise[32]. Subsidiary Performance - Fangcao Company achieved a revenue growth of 45.18% year-on-year during the reporting period, turning a profit from a loss[36]. - Yikang Company reported a 51.79% decrease in revenue, totaling approximately ¥292.33 million, due to prolonged production halts and decreased market demand[39]. - Yikang Company's operating costs decreased by 57.42% to approximately ¥210.75 million, reflecting the impact of reduced sales volume[39]. - Fangcao Company focused on local market channels and internal management adjustments to enhance performance[36]. - Yikang Company's cash and cash equivalents increased by 352.74% to approximately ¥567.31 million, attributed to the transfer of equity stakes[42]. - Accounts receivable for Yikang Company decreased by 48.85% to approximately ¥81.80 million, influenced by the exclusion of certain subsidiaries from consolidation[42]. - Yikang Company's inventory decreased by 56.47% to approximately ¥151.06 million, also due to the exclusion of subsidiaries[42]. Financial Position and Assets - The company's total assets decreased significantly, with fixed assets dropping by 60.88% to CNY 331,857,839.09 from CNY 848,237,087.00[43]. - Long-term equity investments were completely written down to CNY 0, reflecting a 100% decrease from CNY 1,652,476.44[43]. - Deferred tax assets fell by 86.11% to CNY 2,946,890.82 from CNY 21,208,380.61, indicating uncertainty in future tax deductions[43]. - The capital reserve increased by 38.20% to CNY 1,184,901,870.95 from CNY 857,398,769.96, attributed to the difference between the transfer price and the net assets of divested companies[43]. - The company reported a 41.78% decline in undistributed profits, decreasing to CNY 99,846,415.12 from CNY 171,500,064.20, impacted by the exclusion of certain subsidiaries from consolidation[43]. - The total value of restricted assets at the end of the reporting period was CNY 127,748,740.06, primarily due to bank loan collateral[44]. - The company holds CNY 208,787,778.00 in trading financial assets for CITIC Securities, down from CNY 219,092,940.00, reflecting a decrease of 4.5%[46]. Shareholder and Governance - The total number of ordinary shareholders at the end of the reporting period is 50,716[80]. - The largest shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holds 33.34% of the shares[82]. - Liu Wenhua increased his shareholding by 1,971,100 shares during the reporting period[82]. - The company has not proposed any profit distribution or capital reserve transfer plans for the half-year period[64]. - The company has committed to not engaging in any business that competes directly or indirectly with its own operations, ensuring the protection of shareholder rights[66]. - The commitment to avoid conflicts of interest in related transactions has been reaffirmed, with a focus on fair pricing and compliance with market principles[66]. - The company has pledged to maintain its independence and governance structure post-transaction, ensuring the protection of all shareholders' interests[68]. Legal and Compliance - There are no significant lawsuits or arbitration matters reported during the reporting period[70]. - The company has not made any changes to its accounting firm or received a non-standard audit report during the reporting period[70]. - There are no updates on stock incentive plans or employee shareholding plans during the reporting period[70]. - The company has confirmed that it will not use its shares for pledging or guarantees[68]. - The major asset sale and related transactions from 2019 have been disclosed, involving the transfer of equity and debts to the largest shareholder[71]. Cash Flow and Financing Activities - Operating cash flow for the first half of 2020 was negative at -16,721,323.39 RMB, a significant decline from 62,507,766.42 RMB in the same period of 2019, representing a decrease of approximately 126.7%[103]. - Total cash inflow from operating activities decreased to 320,245,371.29 RMB, down 52.5% from 674,085,871.11 RMB in the first half of 2019[103]. - Cash outflow from operating activities increased to 336,966,694.68 RMB, compared to 611,578,104.69 RMB in the previous year, indicating a reduction of 45%[103]. - Cash flow from financing activities was negative at -172,457,458.30 RMB, worsening from -76,110,690.63 RMB in the same period last year, reflecting a decline of 126.5%[104]. Accounting Policies and Estimates - The financial statements were approved for publication by the board of directors on August 25, 2020[126]. - The financial statements are prepared based on the assumption of going concern, with no significant doubts about the company's ability to continue operations for the next 12 months[130]. - The company adheres to the accounting policies and estimates as per the relevant accounting standards, particularly in inventory valuation, fixed asset depreciation, and revenue recognition[131]. - The accounting period for the company runs from January 1 to December 31 each year[133]. - The company's functional currency for accounting purposes is Renminbi (RMB)[135]. Inventory and Asset Management - Inventory is classified as products held for sale, work in progress, and materials consumed in production, with valuation based on cost[188]. - Inventory is initially measured at cost, including procurement and processing costs, and is valued using FIFO or weighted average methods upon issuance[189]. - The company adopts a perpetual inventory system for inventory management[191]. - The net realizable value of inventory is determined based on the lower of cost and net realizable value, with specific methods for different types of inventory[190]. Financial Instruments and Risk Management - The company recognizes expected credit losses for financial assets measured at amortized cost and those measured at fair value with changes recognized in other comprehensive income[173]. - Credit losses are calculated as the present value of cash shortfalls, with specific methods applied based on the stage of credit risk[174]. - The company assesses credit risk based on significant changes in debtor's operational performance, regulatory environment, and collateral value[177].

2020 年第一季度报告 公司代码：600249 公司简称：两面针 柳州两面针股份有限公司 2020 年第一季度报告 1 / 20 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 6 | | 四、 | 附录 8 | 2020 年第一季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 说明：公司于 2019 年 12 月完成控股子公司纸品公司、房开公司的股权转让，自此纸品公司、 房开公司不再纳入公司合并报表范围，故对公司报告期内的利润构成产生一定影响，扣除上述的 两个公司的影响，公司主要会计数据的变动情况如下表： 3 / 20 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度 末增减(%) 总资产 2,456,761,930.75 2,693,598,246.18 -8.79 归属于上市公司股东的 净资产 2,051,686,309.45 2,068,521,257.99 -0.81 年初至报告期末 上年初至上年报告期末 比上年同期增减(%) 经营活动产生的现金流 量净额 -34,076,302.85 8,0 ...

Financial Performance - In 2019, the company reported a net profit attributable to shareholders of -53,805,394.54 RMB, a significant decline compared to a profit of 21,719,714.74 RMB in 2018[20]. - The company's operating revenue for 2019 was 1,186,674,091.12 RMB, representing a decrease of 4.66% from 1,244,728,370.00 RMB in 2018[20]. - The company faced significant challenges, as indicated by a net profit loss of -119,500,060.56 RMB after deducting non-recurring gains and losses[20]. - The basic earnings per share for 2019 was -0.10 CNY, a decrease from 0.04 CNY in 2018[22]. - The net profit attributable to shareholders for Q1 2019 was 47,339,110.07 CNY, but the company reported losses in Q2 (-19,266,438.74 CNY), Q3 (-20,274,082.87 CNY), and Q4 (-61,603,983.00 CNY)[23]. - The net profit after deducting non-recurring items for the year was -76,066,339.80 CNY, indicating a significant loss compared to previous years[24]. - The company reported a net profit of -26.38 million yuan for the fiscal year 2019[104]. - In 2019, the company did not distribute any cash dividends, reflecting a net loss of -53.81 million yuan[105]. Cash Flow and Assets - The net cash flow from operating activities increased to 88,800,489.03 RMB, a substantial rise of 369.84% compared to 18,900,054.92 RMB in 2018[21]. - The total assets of the company at the end of 2019 were 2,693,598,246.18 RMB, reflecting a growth of 6.40% from 2,531,502,988.92 RMB at the end of 2018[21]. - The company reported a total cash flow from operating activities of 8,040,862.19 CNY in Q1, which increased to 54,466,904.23 CNY in Q2, but turned negative in Q3 with -25,928,893.64 CNY, before recovering to 52,221,616.25 CNY in Q4[24]. - The company recorded a total of 2,000,000 CNY in deferred tax assets being reversed due to uncertainties regarding future taxable income[25]. - The company reported a 669.20% increase in other receivables, amounting to 646.15 million yuan, due to the transfer of paper and real estate company debts[58]. - The total current assets amounted to ¥1,924,846,831.74, an increase from ¥831,017,005.66 in 2018, representing a growth of approximately 131%[193]. Operational Efficiency - The company has outlined future plans for sustainable development, emphasizing the importance of new product development and brand promotion[5]. - The company completed a major asset restructuring, selling 84.62% of its stake in the paper company and 80% in the real estate company, resulting in a cash inflow of CNY 587 million[42]. - Research and development expenses increased by 26.65% to CNY 14,252,402.08, reflecting the company's commitment to innovation[44]. - The company maintained its leading position in the hotel toiletries market, adding over 30 high-end hotel clients[40]. - The company focused on the "big consumption, big health" industry, with a strategic shift towards core business areas after divesting from the paper and real estate sectors[39]. - The company emphasized the development of new sales channels, including e-commerce platforms and social retail, to enhance market reach[40]. Revenue Breakdown - Industrial manufacturing revenue was CNY 1,154,499,352.65, with a gross margin of 17.47%, reflecting a year-over-year decrease of 4.25% in revenue and a decrease of 0.79% in cost[46]. - The revenue from commercial trade was CNY 7,049,370.96, with a gross margin of 18.80%, showing a significant year-over-year decline of 17.08% in revenue and 21.07% in cost[47]. - Real estate and property management revenue decreased by 54.82% year-over-year to CNY 2,373,160.97, with a gross margin of 30.23%[47]. - The company’s revenue from daily chemical products reached ¥723,023,531.19, with a gross margin of 22.04%, reflecting a year-over-year increase of 5.32%[75]. - The revenue from pharmaceuticals was ¥108,927,853.61, achieving a gross margin of 38.84%, with a year-over-year increase of 1.43%[75]. Shareholder and Governance - The company’s cash dividend policy remains unchanged during the reporting period, with decisions made by the board based on profitability and funding needs[101]. - The company has committed to maintaining the independence of its operations and protecting the rights of all shareholders[110]. - The company has a policy to consider its industry characteristics and development stage when proposing differentiated cash dividend policies[103]. - The company’s board of directors is responsible for proposing any adjustments to the profit distribution policy, which must be approved by the shareholders' meeting[102]. - The company has established a performance evaluation management system to optimize the compensation management framework[155]. - The company has a clear governance structure, ensuring responsibilities among its power, decision-making, supervisory, and management bodies are well-defined[159]. Environmental and Social Responsibility - The company has established a wastewater treatment plant with a designed daily processing capacity of 60,000 tons, while the actual daily discharge is approximately 10,000 tons, meeting national environmental standards[125]. - The company has donated over CNY 3 million in cash and materials to support COVID-19 relief efforts, demonstrating its commitment to social responsibility[122]. - The company is a vice-chairman unit of the China Oral Care Products Industry Association, contributing to the drafting of industry standards for traditional Chinese medicine toothpaste[122]. - The company has not encountered any situations that would lead to a risk of suspension or termination of its listing[116]. - The company has established an environmental monitoring plan and complies with self-monitoring regulations[130].

Financial Performance - Operating revenue for the first nine months was CNY 881,775,177.12, a decrease of 1.44% year-on-year[7] - Net profit attributable to shareholders increased by 263.51% to CNY 7,798,588.46 compared to the same period last year[7] - Basic earnings per share rose by 264.10% to CNY 0.0142[7] - Total revenue for Q3 2019 was ¥275,357,304.20, a decrease of 10.3% compared to ¥307,050,333.78 in Q3 2018[30] - Net profit for Q3 2019 was a loss of ¥31,440,397.69, compared to a profit of ¥10,596,613.11 in Q3 2018, indicating a significant decline[31] - Total profit for Q3 2019 was CNY 8,257,747.20, a decrease of 63.5% from CNY 22,668,892.50 in Q3 2018[36] - Investment income for Q3 2019 was CNY 13,835,204.82, down 57.1% from CNY 32,277,586.21 in Q3 2018[36] Cash Flow - Cash flow from operating activities for the first nine months was CNY 36,578,872.78, compared to a negative cash flow of CNY -5,505,561.24 in the previous year[7] - The net cash flow from operating activities improved by ¥42,084,434.02, moving from a negative cash flow of ¥5,505,561.24 to a positive cash flow[20] - The net cash flow from investing activities increased by ¥49,663,949.05, also moving from a negative cash flow of ¥8,402,614.19 to a positive cash flow[20] - The net cash flow from operating activities for the first three quarters of 2019 was CNY 36,578,872.78, compared to a net outflow of CNY 5,505,561.24 in the same period of 2018[39] - The net cash flow from investment activities was 69,924,111.68 RMB, significantly higher than 17,069,431.90 RMB in Q3 2018[42] - The net cash flow from financing activities was -9,881,106.92 RMB, an improvement from -26,749,236.11 RMB in Q3 2018[42] Assets and Liabilities - Total assets decreased by 2.66% to CNY 2,464,240,176.87 compared to the end of the previous year[7] - Current assets totaled CNY 951,025,802.33, compared to CNY 831,017,005.66 in the previous year, reflecting an increase of approximately 14.5%[25] - Non-current assets decreased to CNY 1,513,214,374.54 from CNY 1,700,485,983.26, representing a decline of about 11%[25] - Total liabilities were CNY 796,120,173.46, down from CNY 852,876,355.64, indicating a reduction of approximately 6.6%[26] - Current liabilities decreased to CNY 659,633,603.76 from CNY 721,474,381.27, a decline of about 8.5%[26] - The company's total liabilities saw a dramatic increase in notes payable, which rose by 2067.05% to ¥41,355,665.40[16] Shareholder Information - The total number of shareholders as of the report date was 54,570[13] - The largest shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holds 33.34% of the shares[13] Other Financial Metrics - Government subsidies recognized in the first nine months amounted to CNY 6,582,833.51[11] - Non-recurring gains and losses totaled CNY -3,973,778.51 for the first nine months[12] - The company's undistributed profits rose by ¥92,463,295.72, marking a significant increase of 157.35% compared to the previous year[16] - The company's income tax expense surged by 461.26%, amounting to ¥19,048,575.43, due to increased stock market valuations[19] - The company's construction in progress increased by ¥581,884.74, reflecting a growth of 46.86%[16] - Research and development expenses for the first three quarters of 2019 were ¥7,693,021.37, up from ¥6,638,432.68 in the same period of 2018, showing an increase of 15.9%[31] Financial Reporting Changes - The company adopted new financial instrument standards starting January 1, 2019, impacting the classification of financial assets[53] - Adjustments were made to the financial statement format in accordance with the Ministry of Finance's guidelines[53] - The company did not apply retrospective adjustments for prior comparative data under the new leasing standards[54] - The report indicates no applicable audit report for the current financial period[54] - The company has maintained a consistent approach to financial reporting, ensuring compliance with updated regulations[53]

Financial Performance - The company's operating revenue for the first half of 2019 was CNY 606,417,872.92, representing a 3.21% increase compared to CNY 587,567,458.78 in the same period last year[18]. - The net profit attributable to shareholders of the listed company was CNY 28,072,671.33, a significant recovery from a loss of CNY 12,122,782.73 in the previous year[18]. - The net cash flow from operating activities was CNY 62,507,766.42, a turnaround from a negative cash flow of CNY -569,580.02 in the same period last year[18]. - Basic earnings per share for the first half of 2019 were CNY 0.05, compared to a loss of CNY -0.02 per share in the same period last year[19]. - The weighted average return on net assets was 1.55%, recovering from -0.66% in the previous year[19]. - The company achieved operating revenue of CNY 606.42 million, a year-on-year increase of 3.21%[37]. - Net profit attributable to shareholders reached CNY 28.07 million, indicating stable operational performance[34]. - The company reported a net cash flow from operating activities of CNY 62.51 million, a significant improvement from a negative cash flow of CNY 0.57 million in the previous year[37]. - The company reported a net profit of 143,427,392.8 for the current period, showing a positive trend in profitability[124]. - The total comprehensive income for the period is reported at 550,000,000.0, with a significant contribution from the capital reserve and retained earnings[125]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,478,201,417.27, a decrease of 2.11% from CNY 2,531,502,988.92 at the end of the previous year[18]. - The total liabilities decreased to CNY 778,641,016.17 from CNY 852,876,355.64, indicating a reduction of about 8.7%[102]. - The company's current assets totaled CNY 942,466,807.69, an increase from CNY 831,017,005.66 at the end of 2018, reflecting a growth of approximately 13.4%[100]. - The company's total liabilities at the end of the reporting period were 1,757,468,830.6 CNY[136]. - The company's total equity attributable to shareholders increased to CNY 1,824,550,982.40 from CNY 1,796,478,311.07, representing a growth of approximately 1.6%[102]. - The company's equity increased to CNY 2,343,600,112.20 from CNY 2,295,461,275.70, indicating a strengthening of the financial position[106]. Operational Efficiency and Strategy - The company operates in four main sectors: daily chemicals, pharmaceuticals, paper, and real estate, with a focus on the daily chemical sector[26]. - The company is focusing on enhancing its e-commerce platform and external collaborations to drive future growth[34]. - The company is focusing on expanding its product lines and improving operational efficiency across its subsidiaries[54]. - The company aims to focus on its core business and improve operational efficiency to enhance sustainable business capabilities[63]. - The company is committed to strengthening financial management and leveraging its public company platform to secure more financing resources[61]. - The company plans to expand its market presence and invest in new product development to drive future growth[126]. Research and Development - The company has established a research institute for traditional Chinese medicine, focusing on new technologies and products, with three new patents obtained in the first half of 2019[31]. - Research and development expenses for the first half of 2019 were CNY 5,038,976.26, up from CNY 4,311,530.03 in the previous year, indicating a focus on innovation[109]. - Research and development expenses for the first half of 2019 were CNY 2,837,905.51, up from CNY 2,526,106.63 in the same period of 2018[113]. Market and Competition - The company is experiencing intensified market competition in the daily chemical industry, with external brands increasing their market share through innovative marketing and channel expansion[59]. - The company acknowledges the risk of channel structure changes as online sales channels continue to grow, necessitating improvements in resource allocation and conversion rates[59]. Environmental and Regulatory Compliance - The company has implemented environmental protection measures in compliance with national laws and regulations, ensuring that pollutants are discharged within legal limits[75]. - The wastewater treatment facilities are operational and meet the required discharge standards, utilizing a combination of physical and biological treatment methods[75]. - The company has established an emergency response plan for environmental incidents[77]. - The company plans to enhance its environmental protection efforts in response to increasing regulatory scrutiny, particularly in its paper industry segment[60]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,136[90]. - The largest shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holds 183,360,652 shares, representing 33.34% of the total shares[92]. - The second-largest shareholder, Liuzhou Economic Development Investment Co., Ltd., holds 32,959,167 shares, accounting for 5.99% of the total shares[92]. - The company has not proposed any profit distribution or capital reserve transfer plans for the half-year period[65]. Financial Instruments and Accounting - The company has implemented new financial instrument standards starting January 1, 2019, resulting in adjustments to the classification of financial assets, including a reclassification of RMB 444,978,459.35 from "available-for-sale financial assets" to "trading financial assets"[84]. - The company recognizes transaction costs related to business combinations in the current period's profit or loss[161]. - The company measures the fair value of previously held equity interests in the acquired entity on the acquisition date, with any differences recognized in current investment income[166]. - The company assesses expected credit losses based on past events, current conditions, and reasonable forecasts of future economic conditions[193]. Miscellaneous - The company has not reported any significant litigation or arbitration matters during the reporting period[70]. - The company has not disclosed any major related party transactions during the reporting period[70]. - The financial statements were approved by the board on August 22, 2019[147]. - The company has not identified any significant doubts regarding its ability to continue as a going concern[150].

证券代码：600249 证券简称：两面针 公告编号：临2019-012 柳州两面针股份有限公司 关于 2018 年度网上业绩说明会暨投资者 网上集体接待日活动的情况公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、 本次说明会召开情况 柳州两面针股份有限公司（以下简称"公司"）于 2019 年 5 月 28 日 14:00-17:00（网络在线问答时间为 15:30-17:00）召开了 2018 年度网 上业绩说明会暨参加 2019 年广西地区上市公司投资者网上集体接待日 活动。公司董事、副总裁、财务总监王为民先生，董事会秘书韦元贤先 生参加了本次会议，就公司 2018 年度的经营情况及利润分配预案等相 关事宜，与投资者进行了互动交流。 二、 投资者提出的主要问题及公司回复情况 1. 问：2018 年公司业绩有所改善，2019 年是否可以继续保持？ 答：公司 2018 年度扭亏为盈，扣除非经常性损益后净利润大幅减 亏，同上年度比减亏超过 50%。2018 年公司两面针功效型护龈止血牙 膏、两面针天然茶香中药牙膏获 ...

证券代码：600249 证券简称：两面针 公告编号：临2019-011 柳州两面针股份有限公司 关于召开 2018 年度网上业绩说明会暨参加投资者 网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 会议召开时间：2019 年 5 月 28 日（星期二）14:00-17:00，网络在线问答 时间为 15:30-17:00。 ● 会议召开方式：网络在线问答方式 一、 说明会类型 根据《上海证券交易所上市公司现金分红指引》、《关于推进上市公司召开投资 者说明会工作的通知》等相关规定，为进一步加强与投资者的互动交流工作，使广 大投资者更加全面、深入地了解公司 2018 年度的经营情况及利润分配预案等相关 事宜，公司将召开 2018 年度网上业绩说明会暨参加 2019 年广西地区上市公司投资 者网上集体接待日活动。 二、 说明会召开的时间、地点 1.会议召开时间：2019 年 5 月 28 日（星期二）14:00-17:00，网上互动交流时 间为 15:30-17:00。 2.会议召开地 ...

2019 年第一季度报告 公司代码：600249 公司简称：两面针 柳州两面针股份有限公司 2019 年第一季度报告 1 / 25 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 6 | | 四、 | 附录 8 | 2019 年第一季度报告 一、 重要提示 1.4 本公司第一季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 非经常性损益项目和金额 √适用 □不适用 单位：元 币种：人民币 | 项目 | 本期金额 | 说明 | | --- | --- | --- | | 非流动资产处置损益 | -12,239.45 | | | 越权审批，或无正式批准文件，或偶发性的税收返还、减免 | | | | 计入当期损益的政府补助，但与公司正常经营业务密切相关，符合 | 2,469,457.97 | | 3 / 25 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度 末增减(%) 总资产 2,539,973,734.99 2,531,502,988.92 0.33 归属于上市公司股东 的净资产 1,843,817,421.1 ...

Financial Performance - The company achieved a net profit of RMB 49.46 million in 2018, marking a turnaround from a loss in the previous year, but still reported a net loss of RMB 74.73 million after excluding non-recurring gains and losses[6]. - Total revenue for 2018 was RMB 1.24 billion, a decrease of 15.45% compared to RMB 1.47 billion in 2017[21]. - The company's net assets attributable to shareholders decreased by 3.49% to RMB 1.80 billion at the end of 2018, down from RMB 1.86 billion in 2017[22]. - Operating cash flow for 2018 was RMB 18.90 million, a significant improvement from a negative cash flow of RMB 171.05 million in 2017[21]. - The company’s total assets decreased by 6.44% to RMB 2.53 billion in 2018, compared to RMB 2.71 billion in 2017[22]. - Basic earnings per share for 2018 was CNY 0.04, a significant improvement from a loss of CNY 0.26 in 2017[24]. - The company reported a net profit attributable to shareholders of CNY 19,574,351.52 in Q4 2018, compared to a loss of CNY 7,892,075.39 in Q2 2018[25]. - The net cash flow from operating activities in Q4 2018 was CNY 24,405,616.16, showing a recovery from negative cash flow in Q1 2018[26]. - Non-recurring gains and losses totaled CNY 96,447,839.58 in 2018, a significant increase from CNY 9,819,698.47 in 2017[28]. - The company recorded an asset impairment loss of CNY 31,680,000 in Q4 2018, impacting the net profit attributable to shareholders by approximately CNY 26,500,000[26]. Strategic Plans and Investments - The company plans to reinvest the undistributed profits into new product development, brand promotion, and marketing efforts, rather than distributing dividends for 2018[6]. - The company plans to expand its sales channels, including online platforms like Tmall and JD.com, to enhance market reach[33]. - The company aims to integrate its personal care and pharmaceutical sectors to enhance product quality and market reach[39]. - The company’s investment in non-current asset disposal resulted in a gain of CNY 1,363,397.99 in 2018, compared to a loss in the previous year[27]. - The company aims to focus on its core business and enhance the profitability of its main operations, particularly in the daily chemical and pharmaceutical sectors[112]. - The company plans to leverage the national strategy for traditional Chinese medicine to enhance its market position in herbal daily chemical products[110]. - The company aims to expand its e-commerce channels as a key growth driver in the fast-moving consumer goods market[110]. Research and Development - The company’s R&D expenses decreased by 56.42% to CNY 11.25 million, reflecting a strategic focus on cost management[46]. - The company’s effective patents totaled 51, including 37 invention patents, showcasing its strong R&D capabilities[36]. - The company completed 9 R&D projects in oral hygiene products and applied for 5 patents, receiving 2 invention patents in 2018[78]. - The company’s R&D investment accounted for 0.90% of total revenue, with 152 R&D personnel representing 6.36% of the total workforce[62]. Market and Competition - The company faced tight funding conditions and continued operational losses in its main business[6]. - The company is experiencing increased competition in the daily chemical industry, which has entered a mature phase with slow growth and high market segmentation[114]. - The company recognizes the risk of funding difficulties due to stricter monetary policies and its ongoing need for capital to support product development and marketing[117]. - The hotel supplies industry is experiencing rapid growth, with high-end hotel supplies demand expected to increase, indicating a positive market trend[73]. - Jiangsu Industrial Company holds a significant market share in the hotel toiletries sector, with an estimated market share of over 50% for hotel toothpaste products[73]. Environmental and Social Responsibility - The company invested ¥1,602.75 million in environmental protection projects, accounting for 1.29% of total revenue[92]. - The company emphasizes environmental protection and social responsibility in its operations[143]. - The company actively participated in social poverty alleviation, helping 359 registered impoverished individuals to escape poverty in 2018[146]. - The wastewater treatment plant has a designed daily capacity of 60,000 tons, with actual daily discharge of approximately 10,000 tons[149]. - The company operates a 75-ton circulating fluidized bed boiler with complete flue gas treatment facilities, meeting national environmental standards[150]. Governance and Compliance - The company has appointed Dahua Accounting Firm for the audit of its 2018 financial statements, with an audit fee of 500,000 RMB and an internal control audit fee of 280,000 RMB[131]. - The company has not encountered any significant accounting errors that would require correction or impact its financial results[129]. - The company has complied with the new financial reporting format issued by the Ministry of Finance, which does not affect its financial status or operating results for 2018 and prior periods[128]. - The company has established a long-term mechanism to prevent the controlling shareholder from occupying company funds[190]. - The company has a clear governance structure, with responsibilities well-defined among its board, management, and supervisory bodies[188]. Employee Relations - The company engaged in various employee training and development activities, with over 1,100 participants in 2018[144]. - The company provided medical mutual insurance subsidies to over 780 employees, demonstrating its commitment to employee welfare[144]. - The total number of employees in the parent company is 534, while the main subsidiaries employ 1,857, leading to a total of 2,391 employees[183]. - The company emphasizes a performance-based salary system, combining basic and performance pay for directors, supervisors, and senior management[180]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 60,073, down from 61,910 at the end of the previous month, indicating a decrease of approximately 3%[162]. - The largest shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., held 183,360,652 shares, representing 33.34% of the total shares[164]. - The company reported no changes in the structure of assets and liabilities during the reporting period[162]. - The company has no plans for new product development or market expansion mentioned in the report[172].

Financial Performance - Operating revenue for the first nine months was CNY 894,617,792.56, down 16.97% from CNY 1,077,478,914.51 in the same period last year[6] - Net profit attributable to shareholders was CNY 2,145,363.22, a significant improvement from a loss of CNY 70,350,906.64 in the previous year[6] - The company reported a weighted average return on equity of 0.12%, compared to -3.59% in the previous year[6] - Total operating revenue for Q3 2018 was ¥307,050,333.78, a decrease of 14.3% compared to ¥358,243,292.58 in the same period last year[21] - Operating profit for Q3 2018 was ¥15,293,717.87, compared to a loss of ¥4,991,839.00 in the same period last year[22] - Net profit for the first nine months of 2018 was ¥558,234,264.43, an increase from ¥539,686,927.53 in the previous year[20] - The net profit for Q3 2018 reached ¥22,669,222.50, a significant recovery from a net loss of ¥3,655,384.89 in Q3 2017[26] - The total profit for Q3 2018 was ¥22,668,892.50, compared to a loss of ¥3,207,490.19 in the same quarter last year[26] Cash Flow - The net cash flow from operating activities was -CNY 5,505,561.24, compared to -CNY 128,872,561.73 in the same period last year[6] - Operating cash flow improved by 95.73%, with a net cash outflow of ¥5,505,561.24 compared to ¥-128,872,561.70 in the previous period[13] - The net cash flow from operating activities for the first nine months of 2018 was -5,505,561.24 RMB, compared to -128,872,561.73 RMB in the same period last year, indicating an improvement[30] - Total cash inflow from investment activities was 170,896,651.88 RMB, while cash outflow was 179,299,266.07 RMB, resulting in a net cash flow of -8,402,614.19 RMB for the first nine months of 2018[31] - Cash inflow from financing activities amounted to 110,900,000.00 RMB, with cash outflow totaling 165,816,269.75 RMB, leading to a net cash flow of -54,916,269.75 RMB[31] - The net cash flow from investment activities was 17,069,431.90, compared to 25,609,825.05 in the previous year, indicating a decrease[34] - The net cash flow from financing activities was -26,749,236.11, compared to -31,478,250.01 in the previous year, reflecting a slight improvement[35] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,601,029,370.62, a decrease of 3.87% compared to the end of the previous year[6] - Total current assets decreased from CNY 788,549,158.76 at the beginning of the year to CNY 776,065,013.05 by the end of the period, a decline of approximately 1.9%[16] - Total liabilities decreased from CNY 948,190,286.44 to CNY 881,410,124.05, a reduction of about 7.1%[17] - Non-current assets decreased from CNY 1,917,109,958.36 to CNY 1,824,964,357.57, reflecting a decline of approximately 4.8%[16] - The company's cash and cash equivalents dropped from CNY 152,639,668.81 to CNY 83,840,392.03, a decline of approximately 45.0%[16] - The total equity attributable to shareholders decreased from CNY 1,861,493,515.88 to CNY 1,832,996,509.98, a decline of approximately 1.5%[17] - The company's total liabilities increased, with a significant portion attributed to financing activities, reflecting ongoing investment strategies[31] Expenses - Research and development expenses increased slightly to CNY 6,638,432.68, up 0.98% from CNY 6,574,205.21[8] - Sales expenses decreased by 7.76% to CNY 105,324,597.50, while management expenses decreased by 8.31% to CNY 77,414,633.79[8] - Financial expenses were reduced by 21.15% to CNY 17,067,671.61 compared to the previous year[8] - Research and development expenses for Q3 2018 were ¥2,326,902.65, significantly lower than ¥7,568,264.56 in the same period last year[22] - The company's R&D expenses for Q3 2018 were ¥1,368,035.80, slightly up from ¥1,240,724.51 in Q3 2017[26] Shareholder Information - The total number of shareholders at the end of the reporting period was 62,315[10] - The largest shareholder, Guangxi Liuzhou City, held 33.3% of the shares, totaling 183,360,652 shares[10] Investment Performance - Investment income rose by 118.95% to ¥33,900,485.40 from ¥15,483,021.84, driven by increased gains from the sale of stocks and securities[13] - The investment income for Q3 2018 was ¥32,277,586.21, compared to ¥15,463,196.89 in Q3 2017, indicating a strong performance in investments[26] Future Outlook - Future outlook includes a focus on market expansion and new product development, although specific figures were not provided in the report[21] - The company is focusing on improving operational efficiency to enhance cash flow and reduce net losses in future quarters[30]